相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。IFI16 inhibits tumorigenicity and cell proliferation of bone and cartilage tumor cells
Yan Zhang et al.
FRONTIERS IN BIOSCIENCE (2007)
The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention
John P. Alao
MOLECULAR CANCER (2007)
AICAR potentiates ROS production induced by chronic high glucose: Roles of AMPK in pancreatic beta-cell apoptosis
Won-Ho Kim et al.
CELLULAR SIGNALLING (2007)
Elevated E2F1 inhibits transcription of the androgen receptor in metastatic hormone-resistant prostate cancer
Joanne N. Davis et al.
CANCER RESEARCH (2006)
Influence of small interfering RNA corresponding to ets homologous factor on senescence-associated modulation of prostate carcinogenesis
Chaehwa Park et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells
Mahvash Zakikhani et al.
CANCER RESEARCH (2006)
Metformin influences cardiomyocyte cell death by pathways that are dependent and independent of caspase-3
D. An et al.
DIABETOLOGIA (2006)
Ras inhibition results in growth arrest and death of androgen-dependent and androgen-independent prostate cancer cells
Shlomit Erlich et al.
BIOCHEMICAL PHARMACOLOGY (2006)
Metformin treatment to prevent early puberty in girls with precocious pubarche
Lourdes Ibanez et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside and metformin inhibit hepatic glucose phosphorylation by an AMP-activated protein kinase-independent effect on glucokinase translocation
B Guigas et al.
DIABETES (2006)
Inhibition of p38MAPK increases adipogenesis from embryonic to adult stages
M Aouadi et al.
DIABETES (2006)
E2F1 expression in LNCaP prostate cancer cells deregulates androgen dependent growth, suppresses differentiation, and enhances apoptosis
SJ Libertini et al.
PROSTATE (2006)
Metformin prevents high-glucose-induced endothelial cell death through a mitochondrial permeability transition-dependent process
D Detaille et al.
DIABETES (2005)
Metformin and reduced risk of cancer in diabetic patients
JMM Evans et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolism
BB Kahn et al.
CELL METABOLISM (2005)
Development of prostate cancer treatment: The good news
SR Denmeade et al.
PROSTATE (2004)
Cleavage of Mcl-1 by caspases impaired its ability to counteract Bim-induced apoptosis
M Herrant et al.
ONCOGENE (2004)
Minireview: The AMP-activated protein kinase cascade: The key sensor of cellular energy status
DG Hardie
ENDOCRINOLOGY (2003)
Metformin in polycystic ovary syndrome: systematic review and meta-analysis
JM Lord et al.
BRITISH MEDICAL JOURNAL (2003)
AMPK as a metabolic switch in rat muscle, liver and adipose tissue after exercise
NB Ruderman et al.
ACTA PHYSIOLOGICA SCANDINAVICA (2003)
The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism
SA Hawley et al.
DIABETES (2002)
Metformin in non-alcoholic steatohepatitis
G Marchesini et al.
LANCET (2001)
Prevention of pancreatic cancer induction in hamsters by metformin
MB Schneider et al.
GASTROENTEROLOGY (2001)
LKB1, a novel serine/threonine protein kinase and potential tumour suppressor, is phosphorylated by cAMP-dependent protein kinase (PKA) and prenylated in vivo
SP Collins et al.
BIOCHEMICAL JOURNAL (2000)
Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I
MY El-Mir et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)